0000899243-18-027358.txt : 20181024 0000899243-18-027358.hdr.sgml : 20181024 20181024162247 ACCESSION NUMBER: 0000899243-18-027358 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181015 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS STEPHEN CENTRAL INDEX KEY: 0001131146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 181136673 MAIL ADDRESS: STREET 1: NEUROGEN CORP STREET 2: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-15 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001131146 DAVIS STEPHEN 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 1 1 0 0 PRESIDENT AND CEO Stock Option(right to buy) 21.28 2018-10-15 4 A 0 95000 0.00 A 2028-10-15 Common Stock 95000 95000 D Restricted Stock Units 2018-10-15 4 A 0 23750 0.00 A Common Stock 23750 23750 D 25% of the shares subject to the Stock Option vest and become exercisable on October 15, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments. Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. The restricted stock units vest in four equal annual installments beginning October 15, 2019. /s/ Elizabeth N. Carter, Attorney-in-Fact 2018-10-24